Other studies, instead, reported that the number of CD14highCD16- classical monocytes is decreased in COVID-19 patients, while the abundance of inflammatory CD14+CD16+, CD14highCD16+ intermediate, and CD14+CD16high nonclassical monocytes increased according to the severity of COVID-19 [80,82,83]. Here, CD14 is linked to COVID-19.